John Moroney to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications John Moroney has written about Poly(ADP-ribose) Polymerase Inhibitors.
Connection Strength
0.112
-
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. J Natl Compr Canc Netw. 2024 10; 22(8):512-519.
Score: 0.057
-
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer. 2024 Apr 15; 130(8):1234-1245.
Score: 0.054